Key facts
- This page summarizes Martin Davidson's Form 3 filing for AfterNext HealthTech Acquisition Corp..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2021, 20:15.
Martin Davidson - 11 Aug 2021 Form 3 Insider Report for AfterNext HealthTech Acquisition Corp.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 11 Aug 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 11 Aug 2021, 20:15:42 UTC
- Next SEC filing
- 13 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Martin Davidson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Martin Davidson filed Form 3 for AfterNext HealthTech Acquisition Corp. on 11 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AFTR
holding
No securities beneficially owned
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 11 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Martin Davidson is a Partner and the Chief Accounting Officer of TPG. TPG is affiliated with AfterNext HealthTech Sponsor, Series LLC, which directly holds an aggregate of 6,987,500 Class F Ordinary Shares, par value $0.0001 per share, up to 937,500 of which are subject to forfeiture depending on the extent to which the underwriters in the Issuer's initial public offering exercise their over-allotment option.
Footnote F2
Mr. Davidson disclaims beneficial ownership of all of the securities that are or may be beneficially owned by AfterNext HealthTech Sponsor, Series LLC or any of its affiliates. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that Mr. Davidson is, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities of the Issuer.
SEC remarks
Exhibit List